跳到正文

ORBIMED ADVISORS LLC 内部人交易:近期 SEC Form 4 交易

过去 18 个月,ORBIMED ADVISORS LLC(CIK 1055951)在 19 家公司共报告 80 笔 SEC Form 4 内部人交易(最近一笔 2026-09-30)。

日期公司身份类型股数市值
2026-09-30ADARx Pharmaceuticals, Inc. (ADRX)董事买入2.0M$0
2026-09-30ADARx Pharmaceuticals, Inc. (ADRX)董事买入10.7M$0
2026-09-30ADARx Pharmaceuticals, Inc. (ADRX)董事买入769,601$0
2026-09-30ADARx Pharmaceuticals, Inc. (ADRX)董事买入564,187$0
2026-09-30ADARx Pharmaceuticals, Inc. (ADRX)董事买入300,249$5.1M
2026-09-30ADARx Pharmaceuticals, Inc. (ADRX)董事买入7.1M$0
2026-09-30ADARx Pharmaceuticals, Inc. (ADRX)董事买入1.3M$0
2026-09-30ADARx Pharmaceuticals, Inc. (ADRX)董事买入513,067$0
2026-09-30ADARx Pharmaceuticals, Inc. (ADRX)董事买入256,448$0
2026-09-30ADARx Pharmaceuticals, Inc. (ADRX)董事买入61,516$1.0M
2026-09-30ADARx Pharmaceuticals, Inc. (ADRX)董事买入588,235$10.0M
2026-09-23Electra Therapeutics, Inc. (ETRA)董事买入1.1M$0
2026-09-23Electra Therapeutics, Inc. (ETRA)董事买入2.0M$0
2026-09-23Electra Therapeutics, Inc. (ETRA)董事买入1.7M$0
2026-09-23Electra Therapeutics, Inc. (ETRA)董事买入758,279$0
2026-09-23Electra Therapeutics, Inc. (ETRA)董事买入1.0M$15.0M
2026-09-23Electra Therapeutics, Inc. (ETRA)董事买入333,333$5.0M
2026-08-12BlossomHill Therapeutics, Inc. (BLSM)董事买入1.0M$0
2026-08-12BlossomHill Therapeutics, Inc. (BLSM)董事买入1.0M$0
2026-08-12BlossomHill Therapeutics, Inc. (BLSM)董事买入625,000$10.0M
2026-08-11Braveheart Bio, Inc. (BRVE)董事买入9.1M$0
2026-08-11Braveheart Bio, Inc. (BRVE)董事买入1.7M$30.0M
2026-08-11Braveheart Bio, Inc. (BRVE)董事买入273,333$4.9M
2026-07-29Scribe Therapeutics, Inc. (SCTX)董事买入1.0M$15.0M
2026-07-29Scribe Therapeutics, Inc. (SCTX)董事买入348,825$0

来源:SEC Form 4 申报文件 · 截至 2026-09-30